{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T17:25:33Z","timestamp":1781285133951,"version":"3.54.1"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:00:00Z","timestamp":1519948800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1007\/s10792-018-0870-x","type":"journal-article","created":{"date-parts":[[2018,3,2]],"date-time":"2018-03-02T00:21:42Z","timestamp":1519950102000},"page":"777-781","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing\u2013remitting multiple sclerosis"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3869-8593","authenticated-orcid":false,"given":"Mario","family":"Fruschelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Capozzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Gelmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Annunziata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,2]]},"reference":[{"key":"870_CR1","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1056\/NEJM200009283431307","volume":"343","author":"JH Noseworthy","year":"2000","unstructured":"Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG (2000) Multiple sclerosis. N Engl J Med 343:938\u2013952. \n                    https:\/\/doi.org\/10.1056\/NEJM200009283431307","journal-title":"N Engl J Med"},{"key":"870_CR2","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1056\/NEJMoa0909494","volume":"362","author":"L Kappos","year":"2010","unstructured":"Kappos L, Radue EW, O\u2019Connor P, Polman C, Hohlfeld R, Calabresi P, Selmaj K, Agoropoulou C, Leyk M, Zhang-Auberson L, Burtin P for the FREEDOMS Study Group (2010) A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis. New Engl J Med 362:387\u2013401. \n                    https:\/\/doi.org\/10.1056\/NEJMoa0909494","journal-title":"New Engl J Med"},{"key":"870_CR3","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1056\/NEJMoa0907839","volume":"362","author":"JA Cohen","year":"2010","unstructured":"Cohen JA, Barkhof F, Comi G, Hartung HP, Khatri BO, Montalban X, Pelletier J, Capra R, Gallo P, Izquierdo G, Tiel-Wilck K, de Vera A, Jin J, Stites T, Wu S, Aradhye S, Kappos L, for the TRANSFORMS Study Group (2010) Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. New Engl J Med 362:402\u2013415. \n                    https:\/\/doi.org\/10.1056\/nejmoa0907839","journal-title":"New Engl J Med"},{"key":"870_CR4","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology 33:1444\u20131452","journal-title":"Neurology"},{"key":"870_CR5","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1038\/eye.2015.256","volume":"30","author":"G Cennamo","year":"2016","unstructured":"Cennamo G, Romano MR, Vecchio EC, Minervino C, Della Guardia C, Velotti N, Carotenuto A, Montella S, Orefice G, Cennamo G (2016) Anatomical and functional retinal changes in multiple sclerosis. Eye (Lond) 30:456\u2013462. \n                    https:\/\/doi.org\/10.1038\/eye.2015.256","journal-title":"Eye (Lond)"},{"key":"870_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1212\/WNL.0b013e31827b9132","volume":"80","author":"R Nolan","year":"2013","unstructured":"Nolan R, Gelfand JM, Green AJ (2013) Fingolimod treatment in multiple sclerosis leads to increased macular volume. Neurology 80:139\u2013144. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e31827b9132","journal-title":"Neurology"},{"key":"870_CR7","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1016\/j.ophtha.2012.12.040","volume":"120","author":"MA Zarbin","year":"2013","unstructured":"Zarbin MA, Jampol LM, Jager RD, Reder AT, Francis G, Collins W, Tang D, Zhang X (2013) Ophthalmic evaluations in clinical studies of fingolimod (FTY720) in multiple sclerosis. Ophthalmology 120:1432\u20131439. \n                    https:\/\/doi.org\/10.1016\/j.ophtha.2012.12.040","journal-title":"Ophthalmology"},{"key":"870_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ncl.2016.08.012","volume":"35","author":"F Costello","year":"2017","unstructured":"Costello F (2017) Optical coherence tomography in neuro-ophthalmology. Neurol Clin 35:153\u2013163. \n                    https:\/\/doi.org\/10.1016\/j.ncl.2016.08.012","journal-title":"Neurol Clin"},{"key":"870_CR9","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1212\/WNL.0b013e318248deea","volume":"78","author":"N Jain","year":"2012","unstructured":"Jain N, Bhatti MT (2012) Fingolimod-associated macular edema: incidence, detection, and management. Neurology 78:672\u2013680. \n                    https:\/\/doi.org\/10.1212\/WNL.0b013e318248deea","journal-title":"Neurology"},{"key":"870_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ajoc.2016.09.005","volume":"4","author":"MK Soliman","year":"2016","unstructured":"Soliman MK, Sarwar S, Sadiq MA, Jack L, Jouvenat N, Zabad RK, Kedar S, Nguyen QD (2016) Acute onset of fingolimod-associated macular edema. Am J Ophthalmol Case Rep 4:67\u201370","journal-title":"Am J Ophthalmol Case Rep"},{"key":"870_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1097\/WNO.0b013e31829c51f7","volume":"33","author":"KM Winges","year":"2013","unstructured":"Winges KM, Werner JS, Harvey DJ, Cello KE, Durbin MK, Balcer LJ, Calabresi PA, Keltner JL (2013) Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the North American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis. J Neuroophthalmol 33:322\u2013329. \n                    https:\/\/doi.org\/10.1097\/WNO.0b013e31829c51f7","journal-title":"J Neuroophthalmol"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10792-018-0870-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-018-0870-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T06:59:18Z","timestamp":1567234758000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10792-018-0870-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,2]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["870"],"URL":"https:\/\/doi.org\/10.1007\/s10792-018-0870-x","relation":{},"ISSN":["0165-5701","1573-2630"],"issn-type":[{"value":"0165-5701","type":"print"},{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,2]]},"assertion":[{"value":"8 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This is an independent work not supported by any sponsor. The authors have no financial interest regarding the content of this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}